Boss Energy Ltd

BOE

Boss Energy Ltd. engages in the exploration of gold and uranium projects. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2007-07-25. The Honeymoon Uranium Project is located in South Australia, 80 kilometer (km) northwest of the town of Broken Hill. Its Project consists of two main exploration areas (the Eastern and Western tenement regions) with one granted Mining Lease 6109 (ML6109), totaling a 2,595 square kilometer (km2) tenement package, which covers approximately 980 km2 of pastoral leases. The project also consists of five Exploration Leases (EL) covering prospects at Honeymoon and Gould's Dam, 70 km northwest of Honeymoon. The company operates through two segments: Australian uranium operations and Alta Mesa operations. The company also operates 30%-owned Alta Mesa Project in South Texas is a high-grade uranium In-Situ Recovery (ISR) project in South Texas, a prolific United States district for sandstone-hosted ISR production, having produced approximately 80 million pounds (Mlb) historically.

CSL Limited

CSL

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 32,065 full-time employees. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The firm operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others.

Dimerix Limited

DXB

Dimerix Ltd. engages in the investment of the research and development of biopharmaceutical drugs. The company is headquartered in Melbourne, Victoria. The firm is focused on developing lives of patients with inflammatory diseases, including both kidney and respiratory diseases. The company develops and commercializes patient preferred pharmaceutical products for global markets using its receptor technology to identify and develop drugs in areas with an unmet need. The firm is focused on developing its Phase III product candidate DMX-200 (QYTOVRA), for Focal Segmental Glomerulosclerosis (FSGS) kidney disease and is also developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its Receptor Heteromer Investigation Technology (Receptor-HIT) is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets.

Dorsavi Ltd

DVL

dorsaVi Ltd. is a biotechnology company, which focuses on developing motion analysis device technologies for use in clinical practice, elite sports, and occupational health and safety. Its segments include Clinical and Workplace. The firm's products include Workplace Solutions, ViMove+, ViSafe, and Research+. Workplace Solution enables employers to assess risk of injury for employees as well as test the effectiveness of proposed changes to OHS workplace design, equipment or methods based on objective evidence. Its clinical solutions (ViMove, ViMove2 and Professional Suite) provides objective assessment, monitoring outside the clinic and immediate biofeedback. The clinical market is segmented into physical therapy (physiotherapists), hospital in the home, and elite sports. Hospital in the home refers to the remote management of patients by clinicians outside of physical therapy. Elite sports refer to the management and optimization of athletes through objective evidence.

Austal Limited

ASB

Austal Ltd. engages in the design and construction of customized aluminum commercial and defense vessels. The firm offers naval, government and commercial operator ships, systems and support. The firm designs, constructs and supporting commercial vessels, including passenger ferries, vehicle passenger ferries, offshore and windfarm vessels for operators throughout the world. The company offers both defense and commercial operators in maritime technologies to optimize the performance of their ships, operations and their complex on-board information management, communications, radar and weapons systems. The company provides through-life capability management and vessel support services, including crew training and instruction, vessel servicing, repairs and maintenance, integrated logistics support, vessel sustainment and information management systems support. The firm has contracted approximately 350 vessels to over 122 commercial and defense operators in 59 countries worldwide.